Redw Wealth LLC Bristol Myers Squibb CO Transaction History

Redw Wealth LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 09, 2019	SELL	$44.62 - $49.34 $209,714 - $231,898	-4,700 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$45.12 - $53.8 $212,064 - $252,860	4,700 New	4,700 $224,000
Q4 2018 Feb 08, 2019	SELL	$48.76 - $63.23 $302,312 - $392,026	-6,200 Closed	0 $0
Q3 2018 Oct 25, 2018	SELL	$55.19 - $62.25 $65,676 - $74,077	-1,190 Reduced 16.1%	6,200 $385,000
Q2 2018 Aug 03, 2018	SELL	$50.53 - $62.98 $707 - $881	-14 Reduced 0.19%	7,390 $409,000
Q1 2018 May 04, 2018	SELL	$59.92 - $68.98 $20,492 - $23,591	-342 Reduced 4.42%	7,404 $468,000
Q4 2017 Feb 05, 2018	BUY	$59.94 - $65.35 $180,299 - $196,572	3,008 Added 63.49%	7,746 $475,000
Q3 2017 Oct 24, 2017	BUY	$55.23 - $63.74 $261,679 - $302,000	4,738	4,738 $302,000

2,407

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Redw Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Redw Wealth LLC with notifications on news.